Orchestra BioMed Holdings, Inc.
OBIO
$4.49
-$0.08-1.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.48M | 2.82M | 2.94M | 2.89M | 2.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.48M | 2.82M | 2.94M | 2.89M | 2.64M |
| Cost of Revenue | 190.00K | 197.00K | 216.00K | 214.00K | 204.00K |
| Gross Profit | 33.29M | 2.62M | 2.73M | 2.67M | 2.43M |
| SG&A Expenses | 26.91M | 25.53M | 24.09M | 24.30M | 23.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 85.29M | 78.06M | 74.21M | 71.69M | 66.94M |
| Operating Income | -51.81M | -75.24M | -71.27M | -68.80M | -64.30M |
| Income Before Tax | -52.70M | -75.10M | -69.70M | -66.32M | -61.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -52.70 | -75.10 | -69.70 | -66.32 | -61.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.70M | -75.10M | -69.70M | -66.32M | -61.02M |
| EBIT | -51.81M | -75.24M | -71.27M | -68.80M | -64.30M |
| EBITDA | -51.48M | -74.91M | -70.94M | -68.48M | -63.99M |
| EPS Basic | -1.30 | -1.82 | -1.83 | -1.77 | -1.66 |
| Normalized Basic EPS | -0.81 | -1.14 | -1.14 | -1.11 | -1.03 |
| EPS Diluted | -1.30 | -1.82 | -1.83 | -1.77 | -1.66 |
| Normalized Diluted EPS | -0.81 | -1.14 | -1.14 | -1.11 | -1.03 |
| Average Basic Shares Outstanding | 190.78M | 166.88M | 152.31M | 149.72M | 147.26M |
| Average Diluted Shares Outstanding | 190.78M | 166.88M | 152.31M | 149.72M | 147.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |